Claris Lifesciences Ltd. - Research Center
533288 CLARIS Group (B) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 17 |
Sep ' 16 |
Mar ' 16 |
Sep ' 15 |
Jun ' 14 |
Sales |
4.25 |
45.50 |
258.48 |
288.73 |
271.54 |
Operating profit |
-23.99 |
-30.85 |
1.39 |
6.87 |
42.48 |
Interest |
1.65 |
1.83 |
2.74 |
1.13 |
17.76 |
Gross profit |
28.32 |
7.82 |
19.12 |
26.28 |
56.51 |
EPS (Rs) |
310.39 |
1.65 |
2.06 |
-3.23 |
5.53 |
Half yearly
results in details
|
Sep ' 17 |
Sep ' 16 |
Mar ' 16 |
Sep ' 15 |
Jun ' 14 |
Other income |
53.96 |
40.51 |
20.47 |
20.53 |
31.79 |
Stock adjustment |
- |
- |
- |
- |
-2.86 |
Raw material |
- |
- |
- |
- |
40.60 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
18.53 |
12.85 |
8.22 |
10.37 |
29.07 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
9.70 |
63.50 |
248.87 |
271.50 |
162.24 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
2.13 |
1.53 |
2.90 |
3.21 |
16.68 |
Taxation |
9.32 |
-2.70 |
4.99 |
2.88 |
9.66 |
Net profit / loss |
1,693.71 |
9.00 |
11.24 |
-17.65 |
30.17 |
Extra ordinary item |
1,676.84 |
- |
- |
-37.83 |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
54.57 |
54.57 |
54.57 |
54.57 |
54.57 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
212.86 |
212.86 |
Agg.of non promotoholding (%) |
- |
- |
- |
39.01 |
39.01 |
OPM (%) |
-564.29 |
-67.81 |
0.54 |
2.38 |
15.64 |
GPM (%) |
48.66 |
9.10 |
6.85 |
8.50 |
18.63 |
NPM (%) |
2909.82 |
10.46 |
4.03 |
-5.71 |
9.95 |